MedX Health Past Earnings Performance

Past criteria checks 0/6

MedX Health's earnings have been declining at an average annual rate of -10.8%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 17.2% per year.

Key information

-10.8%

Earnings growth rate

-1.9%

EPS growth rate

Medical Equipment Industry Growth-19.2%
Revenue growth rate-17.2%
Return on equityn/a
Net Margin-890.3%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How MedX Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:MDX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 231-531
30 Jun 231-531
31 Mar 230-531
31 Dec 221-531
30 Sep 221-541
30 Jun 221-641
31 Mar 221-641
31 Dec 211-541
30 Sep 211-431
30 Jun 211-431
31 Mar 211-331
31 Dec 201-330
30 Sep 201-430
30 Jun 201-330
31 Mar 201-330
31 Dec 191-331
30 Sep 191-331
30 Jun 191-331
31 Mar 191-441
31 Dec 181-441
30 Sep 181-331
30 Jun 181-331
31 Mar 181-220
31 Dec 171-220
30 Sep 171-220
30 Jun 171-220
31 Mar 171-120
31 Dec 161-120
30 Sep 161-120
30 Jun 161-110
31 Mar 161-110
31 Dec 151010
30 Sep 151-110
30 Jun 151010
31 Mar 151010
31 Dec 141010
30 Sep 141-110
30 Jun 141-210
31 Mar 141-210
31 Dec 131-210
30 Sep 131020
30 Jun 131010

Quality Earnings: MDX is currently unprofitable.

Growing Profit Margin: MDX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MDX is unprofitable, and losses have increased over the past 5 years at a rate of 10.8% per year.

Accelerating Growth: Unable to compare MDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: MDX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.